Aisling Capital Management LP
13 holdingsFiling period: 2026-03-31Current AUM: $511.3Mestimated from latest prices
| # | Ticker | Company | Shares | Reported Value | Current Value | % Portfolio | Change | Date |
|---|---|---|---|---|---|---|---|---|
| 1 | BBIO | BridgeBio Pharma Inc. (BBIO) | 5.09M | $378.0M | $407.6M | 79.72% | -- | 2026-03-31 |
| 2 | SNDX | Syndax Pharmaceuticals, Inc. (SNDX) | 1.32M | $30.8M | $25.1M | 4.91% | -- | 2026-03-31 |
| 3 | GLUE | Monte Rosa Therapeutics Inc (GLUE) | 1.56M | $25.6M | $25.7M | 5.03% | +83.3K | 2026-03-31 |
| 4 | BCAX | Bicara Therapeutics Inc. (BCAX) | 568.9K | $11.3M | $15.4M | 3.01% | -- | 2026-03-31 |
| 5 | BBOT | BridgeBio Oncology Therapeutics (BBOT) | 1.02M | $9.1M | $8.2M | 1.61% | +453.4K | 2026-03-31 |
| 6 | CMPS | Compass Pathways Plc (CMPS) | 1.43M | $7.9M | $16.3M | 3.18% | +233.9K | 2026-03-31 |
| 7 | SRRK | Scholar Rock Holding Corporation (SRRK) | 77.0K | $3.8M | $3.6M | 0.71% | -- | 2026-03-31 |
| 8 | BMEA | Biomea Fusion Inc (BMEA) | 2.05M | $3.1M | $2.4M | 0.47% | -- | 2026-03-31 |
| 9 | EPRX | Eupraxia Pharmaceuticals Inc. (EPRX) | 325.0K | $2.4M | $2.1M | 0.41% | -- | 2026-03-31 |
| 10 | — | Urogen Pharma Ltd. (URGN) | 108.0K | $1.9M | $1.9M | 0.38% | -- | 2026-03-31 |
| 11 | ACRS | Aclaris Therapeutics Inc (ACRS) | 434.5K | $1.6M | $2.3M | 0.44% | -- | 2026-03-31 |
| 12 | MRKR | Marker Therapeutics, Inc. (MRKR) | 325.4K | $422K | $367K | 0.07% | -- | 2026-03-31 |
| 13 | OKUR | OnKure Therapeutics, Inc. (OKUR) | 88.6K | $366K | $338K | 0.07% | -- | 2026-03-31 |
← Scroll →